tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB) tracks Nasdaq Biotechnology Index. SPDR S&P Biotech ETF has $6.02 billion in assets, iShares Biotechnology ...

Wilmington Savings Fund Society FSB trimmed its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 34.4% in ...

today announced it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the “NBI”). CorMedix’s addition to the NBI will become effective prior to the market open on Monday ...

IBB seeks to match the performance of the Nasdaq Biotechnology Index before fees and expenses. The ICE Biotechnology Index contains securities of NASDAQ listed companies that are classified as ...

Stratos Wealth Partners LTD. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.9% ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. Investors should also pay attention to an ETF's expense ratio. Lower cost products will ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.